Molecular biology, TLR7, Immune system, Receptor and TLR8 are his primary areas of study. His Molecular biology research incorporates themes from Tumor necrosis factor alpha and Cytotoxic T cell. To a larger extent, Grayson B. Lipford studies Innate immune system with the aim of understanding TLR7.
Grayson B. Lipford has researched Immune system in several fields, including Adjuvant, In vitro and In vivo. His TLR8 research includes themes of Resiquimod and Virology. His studies deal with areas such as Dendritic cell and Cell biology as well as Toll-like receptor.
The scientist’s investigation covers issues in Immune system, Molecular biology, Immunology, CpG site and Antigen. His Innate immune system and TLR7 investigations are all subjects of Immune system research. His Innate immune system study incorporates themes from Acquired immune system, Dendritic cell and CD14.
His Molecular biology study integrates concerns from other disciplines, such as Cytotoxic T cell, MHC class I, CD40, Oligonucleotide and Peptide. His Antigen study combines topics in areas such as Polynucleotide and Pharmacology. In general Receptor, his work in TLR8 is often linked to TLR9 linking many areas of study.
Grayson B. Lipford mostly deals with Nanocarriers, Immune system, Pharmacology, Biochemistry and Antigen. His research in Immune system tackles topics such as Quinoline which are related to areas like Salt. His study in the field of Oligonucleotide, Antigen-presenting cell and Protein biosynthesis also crosses realms of Cellular transcription.
The various areas that Grayson B. Lipford examines in his Virology study include Conjugated system and Peptide. TLR7 and TLR8 are fields of study that intersect with his CpG Oligodeoxynucleotide research. Grayson B. Lipford integrates TLR7 with TLR9 in his research.
His main research concerns Nanocarriers, Biochemistry, Virology, Pharmacology and Antigen. His Nanocarriers investigation overlaps with other disciplines such as Adjuvant, Cancer research, Population, Nanotechnology and Engineering. Specifically, his work in Biochemistry is concerned with the study of Antigen-presenting cell.
His Virology study combines topics from a wide range of disciplines, such as Peptide and Microbiology. Grayson B. Lipford interconnects TLR7, Toll-like receptor, TLR8 and Immune system in the investigation of issues within Pharmacology. The study incorporates disciplines such as Receptor and Pyrimidine in addition to Antigen.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8
Florian Heil;Hiroaki Hemmi;Hubertus Hochrein;Franziska Ampenberger.
Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition
Stefan Bauer;Carsten J. Kirschning;Hans Häcker;Vanessa Redecke.
Proceedings of the National Academy of Sciences of the United States of America (2001)
Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848
Marion Jurk;Florian Heil;Jörg Vollmer;Christian Schetter.
Nature Immunology (2002)
Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells
Tim Sparwasser;Eva Sophie Koch;Ramunas M. Vabulas;Klaus Heeg.
European Journal of Immunology (1998)
CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation.
Hans Häcker;Harald Mischak;Thomas Miethke;Susanne Liptay.
The EMBO Journal (1998)
CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis.
Stefan Zimmermann;Oliver Egeter;Susanne Hausmann;Grayson B. Lipford.
Journal of Immunology (1998)
The Toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily.
Florian Heil;Parviz Ahmad-Nejad;Hiroaki Hemmi;Hubertus Hochrein.
European Journal of Immunology (2003)
Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner
Mark Rutz;Jochen Metzger;Tanja Gellert;Peter Luppa.
European Journal of Immunology (2004)
Established Human Papillomavirus Type 16-Expressing Tumors Are Effectively Eradicated Following Vaccination with Long Peptides
Sander Zwaveling;Sandra C. Ferreira Mota;Jan Nouta;Mark Johnson.
Journal of Immunology (2002)
Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-alpha-mediated shock.
Tim Sparwasser;Thomas Miethke;Grayson Lipford;Andreas Erdmann.
European Journal of Immunology (1997)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: